Thousand Oaks-based biopharmaceutical giant Amgen announced a new research partnership with the University of Washington’s Institute for Protein Design. Amgen will fund three research projects, although the company has not disclosed financial details of the deal. The collaboration zeros in on the expansion of protein-based therapies by applying IPD’s design techniques to better diversify protein-based…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
